Allen Institute for Immunology and Seattle Children's Research Institute launch study to unravel molecular mysteries of pediatric IBD
SEATTLE, May 13, 2024 /PRNewswire/ -- With pediatric inflammatory bowel disease (IBD) diagnoses on the rise globally, a clinical trial in Seattle aims to transform treatment approaches through deep molecular profiling.
- SEATTLE, May 13, 2024 /PRNewswire/ -- With pediatric inflammatory bowel disease (IBD) diagnoses on the rise globally , a clinical trial in Seattle aims to transform treatment approaches through deep molecular profiling.
- Recruitment has begun for the Seattle STRIDE study , a joint effort by Seattle Children's Research Institute and the Allen Institute for Immunology .
- "IBD is a very complex disease, and we only have a rough understanding of what is happening at a molecular level," she said.
- "There is a universe of information that is not being seen," said Adam Savage , Ph.D., an Assistant Investigator at the Allen Institute for Immunology.